https://www.pharmawire.org/blog daily 0.75 2026-04-24 https://www.pharmawire.org/blog/trump-secures-final-drug-pricing-accord-with-regeneron monthly 0.5 2026-04-25 https://www.pharmawire.org/blog/south-korea-climbs-to-third-in-global-drug-development-pipeline monthly 0.5 2026-04-24 https://www.pharmawire.org/blog/lilly-rejects-subsidised-listing-for-diabetes-drug-amid-pricing-dispute monthly 0.5 2026-04-24 https://www.pharmawire.org/blog/tafamidis-trial-analysts-say-early-signals-point-to-pfizer-pfe-win-upside-for-bridgebio-bbio-downside-for-generics-manufacturers monthly 0.5 2026-04-24 https://www.pharmawire.org/blog/amneal-pharmaceuticals-to-acquire-kashiv-biosciences-in-11bn-deal monthly 0.5 2026-04-23 https://www.pharmawire.org/blog/iran-war-drives-up-cost-of-paracetamol-and-hay-fever-drugs-by-up-to-30-in-england monthly 0.5 2026-04-23 https://www.pharmawire.org/blog/abbvie-to-invest-14bn-in-north-carolina-pharmaceutical-campus monthly 0.5 2026-04-23 https://www.pharmawire.org/blog/adial-clears-manufacturing-hurdle-for-ad04-alcohol-use-disorder-drug-ahead-of-phase-3-trial monthly 0.5 2026-04-22 https://www.pharmawire.org/blog/europe-at-critical-juncture-as-trump-drug-pricing-policy-curbs-new-medicine-launches monthly 0.5 2026-04-22 https://www.pharmawire.org/blog/us-investor-heights-capital-holds-25-of-faron-pharmaceuticals-through-shares-and-convertible-bonds monthly 0.5 2026-04-22 https://www.pharmawire.org/blog/pfizer-set-to-defend-tafamidis-franchise-as-generics-challenge-threatens-165bn-heart-drug-market monthly 0.5 2026-04-22 https://www.pharmawire.org/blog/indiana-pharma-research-group-to-present-crystallinity-research-at-basel-synchrotron-workshop monthly 0.5 2026-04-21 https://www.pharmawire.org/blog/belpointe-opens-174mn-stake-in-regeneron-as-biotech-rides-earnings-beat monthly 0.5 2026-04-21 https://www.pharmawire.org/blog/agios-shares-slide-25-as-novo-nordisk-sickle-cell-data-rattles-rival-drug-programme monthly 0.5 2026-04-21 https://www.pharmawire.org/blog/south-koreas-olix-teams-up-with-ai-drug-design-group-galux-on-next-generation-sirna-therapies monthly 0.5 2026-04-20 https://www.pharmawire.org/blog/uk-filtration-group-amazon-filters-targets-pharma-buyers-at-copenhagen-industry-summit monthly 0.5 2026-04-20 https://www.pharmawire.org/blog/york-biotech-wins-state-funding-to-turn-pharma-waste-into-recyclable-packaging monthly 0.5 2026-04-20 https://www.pharmawire.org/blog/alamar-biosciences-raises-191mn-in-upsized-ipo-as-healthcare-listings-gather-pace monthly 0.5 2026-04-21 https://www.pharmawire.org/blog/fda-accelerated-approval-pathway-lacks-transparency-influential-pricing-body-warns monthly 0.5 2026-04-21 https://www.pharmawire.org/blog/us-food-and-drug-administration-to-convene-expert-panel-on-wider-access-to-peptides monthly 0.5 2026-04-21 https://www.pharmawire.org/blog/middle-east-conflict-threatens-pharma-supply-chains-and-drives-cost-pressures monthly 0.5 2026-04-16 https://www.pharmawire.org/blog/morocco-eu-pharma-trade-gap-widens-as-bloc-posts-record-surplus monthly 0.5 2026-04-16 https://www.pharmawire.org/blog/novo-nordisk-weight-loss-drug-shows-liver-benefits-in-mouse-study monthly 0.5 2026-04-15 https://www.pharmawire.org/blog/merck-to-acquire-terns-for-67bn-in-push-to-offset-keytruda-patent-loss monthly 0.5 2026-04-15 https://www.pharmawire.org/blog/telix-raises-600mn-in-upsized-convertible-bond-offering monthly 0.5 2026-04-15 https://www.pharmawire.org/blog/us-imposes-sweeping-pharma-tariffs-under-section-232-order monthly 0.5 2026-04-15 https://www.pharmawire.org/blog/fda-rebukes-pfizer-over-misleading-adcetris-social-media-ads monthly 0.5 2026-04-14 https://www.pharmawire.org/blog/bridgebio-chief-sells-59mn-in-shares-under-pre-arranged-plan monthly 0.5 2026-04-14 https://www.pharmawire.org/blog/pharma-procurement-blindsided-as-supply-shocks-expose-data-gap monthly 0.5 2026-04-14 https://www.pharmawire.org/blog/novo-nordisk-taps-openai-to-embed-artificial-intelligence-across-drug-pipeline monthly 0.5 2026-04-14 https://www.pharmawire.org/blog/fda-clears-first-generics-of-astrazenecas-farxiga-opening-85bn-market-to-rivals monthly 0.5 2026-04-14 https://www.pharmawire.org/blog/category/News monthly 0.5 https://www.pharmawire.org/home daily 1.0 2026-04-16